Source:http://linkedlifedata.com/resource/pubmed/id/20631312
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-8-5
|
pubmed:abstractText |
Interferon-gamma is crucial for the noncytopathic clearance of hepatitis B virus. In our previous study, we demonstrated that an IFN-gamma-inducible molecule, tripartite motif (TRIM) 22, played an important role in antiviral immunity against hepatitis B virus. However, the molecular mechanism of TRIM22 induction by IFN-gamma is still unclear. In this study, we identified a novel cis-element termed 5' extended IFN-stimulating response element (5' eISRE) that was crucial for IFN-gamma inducibility of TRIM22 through transfection assays with luciferase reporter constructs and EMSAs. The 5' eISRE consists of an ISRE-like motif (ACTTTCGTTTCTC) and a 6-bp sequence (AATTTA) upstream of it, and all three thymine triplets of this cis-element (AATTTAACTTTCGTTTCTC) were revealed to contribute to the IFN-gamma inducibility of TRIM22 by site-directed mutagenesis. Further studies showed that upon IFN-gamma stimulation, the 5' eISRE could be bound by IFN regulatory factor-1 (IRF-1), but not by STAT1, as demonstrated by supershift analysis and an ELISA-based transcription factor assay. Moreover, overexpression of IRF-1 significantly induced TRIM22 expression, whereas silencing of IRF-1 with specific short interference RNA abolished IFN-gamma-induced TRIM22 expression in HepG2 cells, indicating an IRF-1-dependent expression of TRIM22. Taken together, it was demonstrated in this study that a novel cis-element, 5' eISRE, was crucial for the IFN-gamma-induced transcriptional activity of the TRIM22 gene via interaction with IRF-1.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cycloheximide,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon Regulatory Factor-1,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Luciferases,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Synthesis Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Repressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/TRIM22 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1550-6606
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
185
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2314-23
|
pubmed:meshHeading |
pubmed-meshheading:20631312-5' Flanking Region,
pubmed-meshheading:20631312-Base Sequence,
pubmed-meshheading:20631312-Binding Sites,
pubmed-meshheading:20631312-Blotting, Western,
pubmed-meshheading:20631312-Cycloheximide,
pubmed-meshheading:20631312-Electrophoretic Mobility Shift Assay,
pubmed-meshheading:20631312-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:20631312-Hep G2 Cells,
pubmed-meshheading:20631312-Humans,
pubmed-meshheading:20631312-Interferon Regulatory Factor-1,
pubmed-meshheading:20631312-Interferon-gamma,
pubmed-meshheading:20631312-Luciferases,
pubmed-meshheading:20631312-Mutation,
pubmed-meshheading:20631312-Protein Binding,
pubmed-meshheading:20631312-Protein Synthesis Inhibitors,
pubmed-meshheading:20631312-RNA Interference,
pubmed-meshheading:20631312-Recombinant Fusion Proteins,
pubmed-meshheading:20631312-Repressor Proteins,
pubmed-meshheading:20631312-Response Elements,
pubmed-meshheading:20631312-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20631312-Transfection
|
pubmed:year |
2010
|
pubmed:articleTitle |
A 5' extended IFN-stimulating response element is crucial for IFN-gamma-induced tripartite motif 22 expression via interaction with IFN regulatory factor-1.
|
pubmed:affiliation |
Institute for Immunobiology, Department of Immunology, Shanghai Medical College of Fudan University, Shanghai, People's Republic of China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|